Promoter shareholding increased significantly by 73.66% YoY, indicating strong insider confidence despite no changes in Institutions or Public participation.

In contrast to sector averages, where both Promoter and Institution holdings remained flat, QMS Medical's substantial promoter increase signals a potential undervaluation or strategic shift.

The lack of institutional interest, coupled with the significant promoter buying, categorizes this stock as a contrarian favorite, diverging from broader sector sentiment.